Dr. Dave Sonntag, Lt. Col, USAF (Ret)

Chief Scientific Officer

About Dave

Dr. Sonntag spent 23 years with the US Air Force, retiring from active duty in 2014, as a Lt Col, and was the first biomedical science officer appointed as a senior intelligence advisor in the Executive Support Office of the Pentagon in 2006. While there, he provided daily all-source science and technology intelligence support to the Undersecretary of Health Affairs, covering a $50B/year acquisition and medical support portfolio. In this assignment, he analyzed and reported on foreign biomedical trends, especially in Weapons of Mass Destruction and medical countermeasures, including directed-energy weapons. In 2014, while a division chief within the 711th Human Performance Wing of the Air Force Research Lab, he supervised and signed off on the Air Force’s Electromagnetic Bioeffects safety guidelines, still in use today.

From 2006 to 2011, Dr. Sonntag managed program direction and funding levels for new basic science research initiatives in Australasia for the Air Force Office of Scientific Research (AFOSR). During this assignment, he targeted strategic new starts to capitalize on regional strengths in quantum biology, material sciences, nanotechnology, and advanced sensory systems. As Deputy Director of the Tokyo detachment, he traveled extensively throughout Asia, in particular Japan, Singapore, and Korea. During this assignment he oversaw $53M in a broad portfolio at the convergence of Nanotech, Biotech, Information and Cognitive (NBIC) sciences.

During AFOSR sponsorship of research at a major Korean university with national grants in nanotechnology, scientists there confirmed for the first time in 2007 the existence of anatomic structures corresponding to acupuncture meridians. At the same time, a researcher at the National Institute of Material Sciences in Japan was sponsored to study information processing in microtubules, which form a key part of cellular scaffolding, and interact with other organelles known to respond to photobiomodulation. In 2010, Dr. Sonntag provided multiple grants to these researchers, whose work was presented at a landmark Google Workshop on Quantum Biology

Since Global Photon has existing patents that cover the transmission of light into the body via acupuncture meridians, and target cellular organelles known to interact with microtubules, one of Dave’s first tasks as CSO will be to extend these patents to cover precision targeting of externally applied light and other energies from systemic, to tissue, cellular, and sub-cellular levels. The goal will be the right dose, at the right time, and the right place, to tackle systemic problems related to aging and human performance.

Dr. Sonntag’s education includes a PhD in genetic toxicology, MS in Environmental Health and Safety, as well as multiple military training assignments for medical effects of radiological weapons, Bioenvironmental Engineering, intelligence analysis, and Air War College.

Send us a message to learn more.

Would you like to learn more about how you, a family member or the community at large can benefit from the technology behind Lazarus? Contact our global team of experts today.